Clinical Trial Update: Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

View source ↗

Summary

The study reports disease outcomes for sorafenib in patients with advanced renal cell carcinoma treated in community oncology settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Renal Cell Carcinoma | Status: COMPLETED